Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS, INC. (HALO), sold 29,342 shares at $41.50 ($1.2M) on 2020-11-25, disclosed to the SEC on 2020-11-27.
Open-market sale of $1.2M HALO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.50 | 9,671 | $401K | 33.0% |
| 2 | $41.50 | 9,671 | $401K | 33.0% |
| 3 | $41.25 | 10,000 | $413K | 33.9% |
| Total | $41.41 avg | 29,342 | $1.2M | 100% |
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |